science

Obiltoxaximab

Obiltoxaximab is a science topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Obiltoxaximab rather than just read about it. In short: Obiltoxaximab, sold under the brand name Anthim among others, is a monoclonal antibody medication designed for the treatment of exposure to Bacillus anthracis spores (etiologic agent of anthrax). The medication was developed by Elusys Therapeutics, Inc.

Key takeaways

Obiltoxaximab belongs to science; place it in that map before memorising details.
Learn the definition first, then one example that makes the definition concrete.
Connect Obiltoxaximab to a quantity you can measure, compute or draw — that is where exam questions come from.
Reproduce the core statement of Obiltoxaximab from memory before moving on to harder problems.

Reference excerpt

Obiltoxaximab, sold under the brand name Anthim among others, is a monoclonal antibody medication designed for the treatment of exposure to Bacillus anthracis spores (etiologic agent of anthrax). The medication was developed by Elusys Therapeutics, Inc.

Medical uses Obiltoxaximab is indicated in combination with appropriate antibacterial drugs in all age groups for treatment of inhalational anthrax due to Bacillus anthracis. It is also indicated in all age groups for post-exposure prophylaxis of inhalational anthrax when alternative therapies are not appropriate or are not available.

Adverse effects The most frequently reported adverse reactions were headache, pruritus, upper respiratory tract infections, cough, urticaria, nasal congestion, pain in extremity, and injection site reactions such as bruising at site of IV placement, infusion site swelling and infusion site pain.

Legal status In March 2016, obiltoxaximab was approved by the U.S. Food and Drug Administration (FDA) for the treatment and prophylaxis of inhalational anthrax. In September 2020, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion, recommending the granting of a marketing authorization under exceptional circumstances for obiltoxaximab, intended for the treatment or post-exposure prophylaxis of inhalational anthrax. The applicant for this medicinal product is SFL Pharmaceuticals Deutschland GmbH. It was approved for medical use in the European Union in November 2020.

References

External links "Obiltoxaximab". Drug Information Portal. U.S. National Library of Medicine. Archived from the original on May 24, 2021.

Worked examples

Example 1 — a first encounter with Obiltoxaximab

Start with the simplest possible case. Write down what Obiltoxaximab claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In science, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Obiltoxaximab before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Obiltoxaximab ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Obiltoxaximab

In research: Obiltoxaximab appears in science research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry: Engineering practice reuses Obiltoxaximab in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom: Obiltoxaximab is common in secondary-school and first-year university syllabi. It links to neighbouring topics Monoclonal antibodies, Orphan drugs, so understanding it makes those chapters shorter.
In everyday life: Look for Obiltoxaximab outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Obiltoxaximab” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Obiltoxaximab in 20 minutes

Read the reference excerpt below once, without taking notes.
Close the page and write down what Obiltoxaximab means in your own words.
Compare your version with the excerpt and mark what you missed.
Work through the three examples above with pen and paper.
Explain Obiltoxaximab out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Obiltoxaximab in simple terms?

Why does Obiltoxaximab matter?

Because it connects several science ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Obiltoxaximab?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Obiltoxaximab.